Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Reinhard Schliebs, Thomas Arendt
Journal of Neural Transmission (2006) Vol. 113, Iss. 11, pp. 1625-1644
Closed Access | Times Cited: 506

Showing 26-50 of 506 citing articles:

Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease
Michel J. Grothe, Helmut Heinsen, Stefan Teipel
Neurobiology of Aging (2012) Vol. 34, Iss. 4, pp. 1210-1220
Open Access | Times Cited: 169
Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits
Celine Ullrich, Michael Pirchl, Christian Humpel
Molecular and Cellular Neuroscience (2010) Vol. 45, Iss. 4, pp. 408-417
Open Access | Times Cited: 158
Acetylcholine and memory: A long, complex and chaotic but still living relationship
Jacques Micheau, Aline Marighetto
Behavioural Brain Research (2010) Vol. 221, Iss. 2, pp. 424-429
Closed Access | Times Cited: 149
The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer’s disease
Chun Chen, Zhihao Wang, Zhentao Zhang, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 3, pp. 578-583
Open Access | Times Cited: 149
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects
Eugenie Nepovimová, Elisa Uliassi, Jan Korábečný, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 20, pp. 8576-8589
Closed Access | Times Cited: 145
Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes
Tiago Silva, Joana Reis, José Teixeira, et al.
Ageing Research Reviews (2014) Vol. 15, pp. 116-145
Closed Access | Times Cited: 145
Taurine and central nervous system disorders
Janet Menzie, Chunliu Pan, Howard Prentice, et al.
Amino Acids (2012) Vol. 46, Iss. 1, pp. 31-46
Closed Access | Times Cited: 144
Alzheimer’s Disease Amyloid β-Protein and Synaptic Function
Tomáš Ondrejčák, Igor Klyubin, Neng‐Wei Hu, et al.
NeuroMolecular Medicine (2009) Vol. 12, Iss. 1, pp. 13-26
Closed Access | Times Cited: 140
Organoselenium compounds as mimics of selenoproteins and thiol modifier agents
Nilda Vargas Barbosa, Cristina W. Nogueira, Pablo A. Nogara, et al.
Metallomics (2017) Vol. 9, Iss. 12, pp. 1703-1734
Closed Access | Times Cited: 138
The cholinergic system, EEG and sleep
Bettina Platt, Gernot Riedel
Behavioural Brain Research (2011) Vol. 221, Iss. 2, pp. 499-504
Closed Access | Times Cited: 134
The role of aquaporin-4 in synaptic plasticity, memory and disease
Jacqueline A. Hubbard, Jenny I. Szu, Devin K. Binder
Brain Research Bulletin (2017) Vol. 136, pp. 118-129
Closed Access | Times Cited: 126
Regulation of cholinergic activity by the vesicular acetylcholine transporter
Vânia F. Prado, Ashbeel Roy, Benjamin Kolisnyk, et al.
Biochemical Journal (2013) Vol. 450, Iss. 2, pp. 265-274
Closed Access | Times Cited: 125
Neurotransmitters couple brain activity to subventricular zone neurogenesis
Stephanie Z. Young, M. Morgan Taylor, Angélique Bordey
European Journal of Neuroscience (2011) Vol. 33, Iss. 6, pp. 1123-1132
Open Access | Times Cited: 119
Multi-targetable chalcone analogs to treat deadly Alzheimer’s disease: Current view and upcoming advice
Xu Zhang, K.P. Rakesh, Syed Nasir Abbas Bukhari, et al.
Bioorganic Chemistry (2018) Vol. 80, pp. 86-93
Closed Access | Times Cited: 114
Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy
Giulia Gava, Isabella Orsili, Stefania Alvisi, et al.
Medicina (2019) Vol. 55, Iss. 10, pp. 668-668
Open Access | Times Cited: 114
Alpha-Band Hypersynchronization in Progressive Mild Cognitive Impairment: A Magnetoencephalography Study
María Eugenia López, Ricardo Bruña, Sara Aurtenetxe, et al.
Journal of Neuroscience (2014) Vol. 34, Iss. 44, pp. 14551-14559
Open Access | Times Cited: 113
Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment
Michel J. Grothe, Helmut Heinsen, Edson Amaro, et al.
Cerebral Cortex (2015) Vol. 26, Iss. 6, pp. 2411-2426
Open Access | Times Cited: 110
Acetyl-CoA the Key Factor for Survival or Death of Cholinergic Neurons in Course of Neurodegenerative Diseases
Andrzej Szutowicz, Hanna Bielarczyk, Agnieszka Jankowska-Kulawy, et al.
Neurochemical Research (2013) Vol. 38, Iss. 8, pp. 1523-1542
Open Access | Times Cited: 108
Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease
Stefan Teipel, Helmut Heinsen, Edson Amaro, et al.
Neurobiology of Aging (2013) Vol. 35, Iss. 3, pp. 482-491
Open Access | Times Cited: 103
Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects
Michel J. Grothe, Michael Ewers, Bernd J. Krause, et al.
Alzheimer s & Dementia (2014) Vol. 10, Iss. 5S
Open Access | Times Cited: 96
The Role of Astrocytic Aquaporin-4 in Synaptic Plasticity and Learning and Memory
Jenny I. Szu, Devin K. Binder
Frontiers in Integrative Neuroscience (2016) Vol. 10
Open Access | Times Cited: 96
Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers
Monika Rana, Anuj K. Sharma
Metallomics (2018) Vol. 11, Iss. 1, pp. 64-84
Closed Access | Times Cited: 92
Long‐term potentiation–like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset
Francesco Di Lorenzo, Viviana Ponzo, Sonia Bonnı̀, et al.
Annals of Neurology (2016) Vol. 80, Iss. 2, pp. 202-210
Open Access | Times Cited: 91
5-HT3Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld‐Johnsen, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 383-412
Open Access | Times Cited: 88
Effects of food-derived bioactive peptides on cognitive deficits and memory decline in neurodegenerative diseases: A review
Shuguang Wang, Dongxiao Sun‐Waterhouse, Geoffrey I. N. Waterhouse, et al.
Trends in Food Science & Technology (2021) Vol. 116, pp. 712-732
Closed Access | Times Cited: 72

Scroll to top